V66M (p.Val66Met) variant of ALDOB (Fructose-bisphosphate aldolase B)

V66M (p.Val66Met) in ALDOB (Fructose-bisphosphate aldolase B) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.40 / 1. The record also includes population frequency data and structural context.

V66M (p.Val66Met) variant details